Posted inHealth
Eli Lilly to Acquire Kelonia Therapeutics in $7B Deal for In Vivo CAR-T Cancer Therapy
Eli Lilly’s agreement to buy Kelonia Therapeutics for as much as $7 billion is not just another biotech takeover. It is a clear sign that large drugmakers are willing to…







